View in EDS HTML Full Text PDF Full Text

CAR/CXCR5-T cell immunotherapy is safe and potentially efficacious in promoting sustained remission of SIV infection.

Saved in:
Bibliographic Details
Title: CAR/CXCR5-T cell immunotherapy is safe and potentially efficacious in promoting sustained remission of SIV infection.
Authors: Pampusch, Mary S.1 (AUTHOR), Abdelaal, Hadia M.1 (AUTHOR), Cartwright, Emily K.1 (AUTHOR), Molden, Jhomary S.1 (AUTHOR), Davey, Brianna C.1 (AUTHOR), Sauve, Jordan D.1 (AUTHOR), Sevcik, Emily N.1 (AUTHOR), Rendahl, Aaron K.1 (AUTHOR), Rakasz, Eva G.2 (AUTHOR), Connick, Elizabeth3 (AUTHOR), Berger, Edward A.4 (AUTHOR), Skinner, Pamela J.1 (AUTHOR) skinn002@umn.edu
Source: PLoS Pathogens. 2/7/2022, Vol. 18 Issue 2, p1-30. 30p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:15537366
DOI:10.1371/journal.ppat.1009831